Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer
about
Targeting Neovasculature with Multitargeted Antiangiogenesis Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.Lack of effect of smoking status on axitinib pharmacokinetics in patients with non-small-cell lung cancer.Hypertension in malignancy-an underappreciated problem.Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?
P2860
Phase II study of axitinib with doublet chemotherapy in patients with advanced squamous non-small-cell lung cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@ast
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@en
type
label
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@ast
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@en
prefLabel
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@ast
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@en
P2093
P2860
P1433
P1476
Phase II study of axitinib wit ...... ous non-small-cell lung cancer
@en
P2093
Antonella Ingrosso
Cristina L Cebotaru
Paul Bycott
P2860
P2888
P356
10.1186/S12885-015-1350-6
P407
P577
2015-05-01T00:00:00Z
P5875
P6179
1021939244